Novel coating for stents could lower odds of blood clotting

09/9/2013 |

A study in Arteriosclerosis, Thrombosis, and Vascular Biology found that coating stents with CTP synthase 1 inhibitors such as cyclopentenyl cytosine may help inhibit smooth muscle cell proliferation, potentially cutting the risk of blood clots. "Our study identified CTPS1 as a novel target for developing anti-neointima drugs that are SMC-sensitive but have little side-effect on re-endothelialization during vascular repair," researchers said.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Chicago, IL
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC